What is William Blair's Forecast for Neogen FY2025 Earnings?

Neogen Co. (NASDAQ:NEOG - Free Report) - Research analysts at William Blair dropped their FY2025 earnings per share estimates for shares of Neogen in a report issued on Monday, April 14th. William Blair analyst B. Vazquez now forecasts that the company will earn $0.31 per share for the year, down from their previous estimate of $0.32. The consensus estimate for Neogen's current full-year earnings is $0.38 per share. William Blair also issued estimates for Neogen's Q4 2025 earnings at $0.08 EPS, FY2026 earnings at $0.36 EPS and FY2027 earnings at $0.42 EPS.

Neogen (NASDAQ:NEOG - Get Free Report) last posted its quarterly earnings data on Wednesday, April 9th. The company reported $0.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.02). The company had revenue of $221.00 million for the quarter, compared to analyst estimates of $225.27 million. Neogen had a negative net margin of 52.12% and a positive return on equity of 2.89%. The business's revenue was down 3.4% compared to the same quarter last year. During the same quarter last year, the company earned $0.12 EPS.

Several other equities analysts also recently issued reports on the company. Piper Sandler cut their target price on Neogen from $13.00 to $6.50 and set a "neutral" rating on the stock in a research report on Monday, April 14th. Guggenheim dropped their target price on Neogen from $15.00 to $13.00 and set a "buy" rating on the stock in a research report on Thursday, April 10th.

Neogen Stock Performance

Neogen stock traded down $0.21 during mid-day trading on Wednesday, reaching $4.39. 12,563,404 shares of the company traded hands, compared to its average volume of 2,636,796. Neogen has a fifty-two week low of $3.87 and a fifty-two week high of $18.58. The firm's fifty day moving average is $8.51 and its two-hundred day moving average is $11.60. The company has a debt-to-equity ratio of 0.33, a current ratio of 3.77 and a quick ratio of 2.46. The company has a market capitalization of $952.80 million, a price-to-earnings ratio of -2.00 and a beta of 1.57.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in NEOG. Harbour Investments Inc. acquired a new stake in shares of Neogen during the 4th quarter valued at about $27,000. Versant Capital Management Inc boosted its position in Neogen by 1,495.4% during the first quarter. Versant Capital Management Inc now owns 3,127 shares of the company's stock worth $27,000 after purchasing an additional 2,931 shares in the last quarter. Blue Trust Inc. grew its holdings in Neogen by 196.7% in the fourth quarter. Blue Trust Inc. now owns 3,368 shares of the company's stock valued at $41,000 after purchasing an additional 2,233 shares during the period. Johnson Financial Group Inc. purchased a new stake in shares of Neogen in the fourth quarter valued at approximately $43,000. Finally, Covestor Ltd raised its stake in shares of Neogen by 41.4% during the 4th quarter. Covestor Ltd now owns 4,103 shares of the company's stock worth $50,000 after buying an additional 1,202 shares during the period. Hedge funds and other institutional investors own 96.73% of the company's stock.

Insider Activity at Neogen

In related news, CAO John Patrick Moylan purchased 10,000 shares of the firm's stock in a transaction on Thursday, April 10th. The stock was bought at an average cost of $5.07 per share, with a total value of $50,700.00. Following the completion of the acquisition, the chief accounting officer now owns 10,000 shares of the company's stock, valued at $50,700. The trade was a ∞ increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 1.13% of the stock is currently owned by insiders.

Neogen Company Profile

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.